Oragenics, Inc. (OGEN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Oragenics, Inc. on July 1, 2021, covering events occurring on June 30, 2021. The filing addresses the status of the Company's Annual Meeting of Shareholders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance events rather than financial performance data.
Material Changes and Events
- Failed Quorum: On June 30, 2021, the Annual Meeting was called to order but lacked a sufficient number of shares present or represented by proxy to constitute a quorum.
- Adjournment: The meeting was adjourned and rescheduled for August 23, 2021, at 4:00 p.m. Eastern Time.
- New Location: The reconvened meeting will be held at the offices of Shumaker, Loop, & Kendrick in Tampa, FL.
- Record Date: The record date for the meeting remains May 5, 2021.
- Proposals: No changes have been made to the proposals to be voted on by shareholders.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on business outlook, or specific risk factors beyond the procedural risk of the meeting adjournment. Shareholders are directed to the definitive proxy statement (Schedule 14A) filed on May 24, 2021, for detailed information on proposals and risks.
Key Facts for Investor Verification
- Verify the new meeting date of August 23, 2021, and the physical location in Tampa, FL.
- Confirm whether the lack of quorum indicates low shareholder engagement or potential issues with proxy solicitation.
- Review the Schedule 14A Proxy Statement filed on May 24, 2021, for details on the specific proposals pending a vote.
- Check if shareholders who previously voted need to take any action to ensure their votes count at the adjourned meeting (filing states no action is needed if votes are not being changed).